DAPHNE Chatbot for Social Needs

Overseen By Emre Sezgin, PhD

Age: 18+

Sex: Any

Trial Phase: Academic

Sponsor: Emre Sezgin

Disqualifiers: Non-English speakers

No Placebo Group All trial participants will receive the active study treatment (no placebo)

Compensation: Varies

Number of Visits: 1

Duration: 6 months

70 Participants Needed

What You Need to Know Before You Apply

What is the purpose of this trial?

The goal of this clinical trial is to learn if the DAPHNE chatbot can improve caregiver engagement, usability, and integration of social care support tools into clinical workflows in caregivers of pediatric patients receiving care at the Nationwide Children's Hospital Primary Care Center (NCH PCC). This is a pilot randomized clinical trial.

The main questions it aims to answer are:

* Is the DAPHNE chatbot usable, acceptable, and minimally burdensome for caregivers over a 6-month period?

* Can the DAPHNE chatbot be effectively integrated into primary care provider workflows?

Researchers will compare the DAPHNE chatbot intervention arm to the standard of care control arm to see if the intervention improves caregiver-reported outcomes and provider workflow integration.

Participants that are patients will be randomly assigned to either the DAPHNE chatbot group or the standard of care group. Complete surveys assessing usability, acceptability, and burden and participate in brief qualitative interviews to share feedback on their experience.

Participants that are Primary Care providers will discuss integration of DAPHNE into clinical workflows and complete workflow integration assessments.

Who Is on the Research Team?

Emre Sezgin, PhD

Principal Investigator

Nationwide Children's Hospital

Are You a Good Fit for This Trial?

This trial is for caregivers of pediatric patients at NCH PCC. It's designed to see if a chatbot named DAPHNE can help them better engage with health and social care support tools. Caregivers will be asked to use the chatbot, fill out surveys, and participate in interviews.

Inclusion Criteria

* Must be 18 years or older

* At least one unmet social need

* Low-income

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants are randomly assigned to either the DAPHNE chatbot group or the standard of care group and complete surveys assessing usability, acceptability, and burden.

6 months

Continuous engagement with the chatbot and periodic surveys

Follow-up

Participants are monitored for retention and outcomes through follow-up assessments.

6 months

1 month, 3 months, and 6 months post-baseline assessments

What Are the Treatments Tested in This Trial?

Interventions

• DAPHNE Chatbot Intervention

Trial Overview The study tests whether the DAPHNE chatbot improves caregiver engagement compared to usual care involving standard HRSN screening and referral. It's a pilot randomized clinical trial focusing on usability, acceptability, burden over six months, and integration into provider workflows.

How Is the Trial Designed?

Group I: Health Care Providers Experimental Treatment 1 Intervention

All health care providers will receive access to the chatbot.

Group II: Chatbot Access Experimental Treatment 1 Intervention

These participants will receive access to the chatbot

Group III: Standard of Care Active Control 1 Intervention

Participants will not receive access to the DAPHNE chatbot. These individuals will receive the usual HRSN screening/referral procedures at Nationwide Children's Hospital.

Who Is Running the Clinical Trial?

Emre Sezgin

Lead Sponsor